Kasugamycin-resistant mutants of Bacillus subtilis

Area of Science:

• Microbiology
• Molecular Biology
• Genetics

Background:

• Bacillus subtilis is a model organism for studying bacterial genetics and sporulation.
• Antibiotic resistance is a growing global health concern.
• Kasugamycin is an aminoglycoside antibiotic used to control bacterial diseases.

Purpose of the Study:

• To isolate and characterize kasugamycin-resistant mutants of Bacillus subtilis.
• To investigate the genetic basis of kasugamycin resistance.
• To understand the relationship between kasugamycin resistance and other antibiotic resistances.

Main Methods:

• Isolation of kasugamycin-resistant mutants.
• In vitro protein synthesis assays.
• Antibiotic susceptibility testing.
• Genetic mapping of resistance loci.

Main Results:

• Two distinct groups of kasugamycin-resistant mutants were identified.
• Group 1 mutants showed resistance in vitro protein synthesis and mapped to the ribosomal region.
• Group 2 mutants lacked in vitro protein synthesis resistance but displayed weak cross-resistance to gentamicin and kanamycin.
• Neither mutant group could sporulate in the presence of kasugamycin.

Conclusions:

• Kasugamycin resistance in Bacillus subtilis can arise through different mechanisms.
• Ribosomal mutations confer direct kasugamycin resistance.
• Alternative resistance mechanisms may involve cross-resistance to other antibiotics.
• Sporulation is sensitive to kasugamycin, irrespective of the resistance mechanism.